Anti-MDA5 dermatomyositis and progressive interstitial pneumonia

被引：27
|
作者：
Silveira, M. G. [1 ]
Selva-O'Callaghan, A. [2 ]
Ramos-Terrades, N. [3 ]
Arredondo-Agudelo, K. V. [3 ]
Labrador-Horrillo, M. [2 ]
Bravo-Masgoret, C. [1 ]
机构：
[1] Univ Autonoma Barcelona, Vall DHebron Gen Hosp, Pneumol, Barcelona 08035, Spain
[2] Univ Autonoma Barcelona, Vall DHebron Gen Hosp, Internal Med, Barcelona 08035, Spain
[3] Univ Autonoma Barcelona, Vall DHebron Gen Hosp, Dept Nephrol, Barcelona 08035, Spain
来源：
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | 2016年 / 109卷 / 01期
关键词：
LUNG-DISEASE;
D O I：
10.1093/qjmed/hcv068
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [31] Multidisciplinary approach to anti-MDA5 antibody-positive dermatomyositis associated with rapidly progressive interstitial lung disease
    Witkowska, Anna Barbara
    Cowley, Sharon
    Dempsey, Philip
    Stack, John
    BMJ CASE REPORTS, 2022, 15 (03)
  • [32] Interstitial lung disease-associated with amyopathic dermatomyositis and anti-MDA5 autoantibodies
    Gerfaud-Valentin, M.
    Ahmad, K.
    Piegay, F.
    Fabien, N.
    Raphanel, B.
    Cordier, J. -F.
    Cottin, V.
    REVUE DES MALADIES RESPIRATOIRES, 2014, 31 (09) : 849 - 853
  • [33] Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease
    A. Selva-O’Callaghan
    F. Romero-Bueno
    E. Trallero-Araguás
    A. Gil-Vila
    J. C. Ruiz-Rodríguez
    O. Sánchez-Pernaute
    I. Pinal-Fernández
    Current Treatment Options in Rheumatology, 2021, 7 : 319 - 333
  • [34] Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease
    Selva-O'Callaghan, A.
    Romero-Bueno, F.
    Trallero-Araguas, E.
    Gil-Vila, A.
    Ruiz-Rodriguez, J. C.
    Sanchez-Pernaute, O.
    Pinal-Fernandez, I.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2021, 7 (04) : 319 - 333
  • [35] Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome
    Tanaka, Nao
    Terao, Chikashi
    Nakayama, Yoichi
    Sasai, Tsuneo
    Umezawa, Natsuka
    Yagyu, Yuriko
    Ito, Kanae
    Koike, Ryuji
    Nakashima, Ran
    Hatta, Kazuhiro
    Mizoguchi, Fumitaka
    RHEUMATOLOGY, 2021, 60 (03) : E104 - E106
  • [36] Dermatomyositis associated with anti-MDA5 antibodies and pneumocystis pneumonia: Two lethal cases
    Aymonier, M.
    Abed, S.
    Boye, T.
    Barazzutti, H.
    Fournier, B.
    Morand, J. -J.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2017, 144 (04): : 279 - 283
  • [37] Anti-MDA5 dermatomyositis mimicking psoriatic arthritis
    Cabezas-Rodriguez, Ivan
    Morante-Bolado, Isla
    Brandy-Garcia, Anahy
    Queiro-Silva, Ruben
    Mozo, Lourdes
    Javier Ballina-Garcia, Francisco
    REUMATOLOGIA CLINICA, 2018, 14 (04): : 224 - 226
  • [38] Bosentan for Cutaneous Ulcers in Anti-MDA5 Dermatomyositis
    Combalia, Andrea
    Giavedoni, Priscila
    Tamez, Lorena
    Grau-Junyent, Josep M.
    Mascaro, Jose M., Jr.
    JAMA DERMATOLOGY, 2018, 154 (03) : 371 - 373
  • [39] Relapsing Hematoma Secondary to Anti-MDA5 Dermatomyositis
    Zhu, Fenglin
    Li, Chengyin
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 (03) : E17 - E17
  • [40] ANTI-MDA5 POSITIVE DERMATOMYOSITIS: AN EMERGING ENTITY
    Ortiz-Santamaria, V.
    Ponce, A.
    Busquets, N.
    Del Castillo, N.
    Suris, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1289 - 1289
12345